ASFAR PIERRE ET AL: "Angiotensin-II: more than just another vasoconstrictor to treat septic shock-induced hypotension?*", CRITICAL CARE MEDICINE, LIPPINCOTT WILLIAMS & WILKINS, US, vol. 42, no. 8, 1 August 2014 (2014-08-01) , pages 1961-1963, XP009189463, ISSN: 1530-0293 (B1)

Anonymous: "NCT01393782 on 2013_03_14", , 14 March 2013 (2013-03-14), XP055324476, Retrieved from the Internet: URL:https://clinicaltrials.gov/archive/NCT 01393782/2013_03_14 [retrieved on 2016-11-30] (B1)

CHAWLA, L.S. ET AL.: 'Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study' CRITICAL CARE vol. 18, no. ISSUE, 06 October 2014, XP055302988 (B1)

L W BUSSE ET AL: "Angiotensin II may be useful for the treatment of hypotension in distributive shock, but a safe and effi cacious dose is unknown", CRITICAL CARE, vol. 18, no. Suppl 1, 17 March 2014 (2014-03-17), page S57, XP055264430, DOI: 10.1186/cc13350 (B1)

LI, T. ET AL.: 'Changes in sensitivity of vascular smooth muscle to calcium and its role in the biphasic change in vascular reactivity following hemorrhagic shock in rats' CHINESE CRITICAL CARE MEDICINE vol. 17, no. 11, November 2005, pages 647 - 650, XP008182418 (B1)

YUNGE, M. ET AL.: 'Angiotensin for septic shock unresponsive to noradrenaline' ARCHIVES OF DISEASE IN CHILDHOOD vol. 82, no. ISSUE, May 2000, pages 388 - 389, XP003015357 (B1)

THOMAS, V.L. ET AL.: 'Administration of angiotensin II in refractory septic shock' CRITICAL CARE MEDICINE vol. 19, no. 8, August 1991, pages 1084 - 1086, XP008179391 (B1)

US-A1- 2011 144 026 (B1)

WO-A1-2016/007589 (B1)

WRAY, G.M. ET AL.: 'Severe septic shock unresponsive to noradrenaline' THE LANCET vol. 346, no. 8990, December 1995, page 1604, XP002111951 (B1)

NIU, C.Y. ET AL.: 'Lymphatic hyporeactivity and calcium desensitization following hemorrhagic shock' SHOCK vol. 37, no. 4, April 2012, pages 415 - 423, XP055302951 (B1)